All factors that affect life expectancy can be divided into immediate and indirect. The latter ones include economic development and economic contribution, financial support for health care and social determinants. The social determinants account for up to 40% of the impact, but they cannot be effective bypassing the primary factors that affect morbidity and mortality — Veronika Skvortsova, Minister of Health of the Russian Federation.

Health should become a strategy not only for the medical industry, but for all sectors of the economy in our country’s municipalities — Oleg Kuvshinnikov, Governor of Vologda Region; Chairman, Healthy Cities, Districts, and Villages Association.

The health of the population is determined by three main factors: social and economic conditions take about 40%; lifestyle, alcohol and tobacco consumption are responsible for about 30%; the remaining 30% fall on the health care system — Guzel Ulumbekova, President of the Board, Association of Medical Societies for Quality of Medical Care and Medical Education; Head, Higher School of Healthcare Organization and Management, MD.

This year, 4.5% of the enterprises that applied for Roskachestvo audit are medical and pharmaceutical ones — Maxim Protasov, Head of the Russian Quality System (Roskaschestvo).

Today we need to talk about the quality of life, not life expectancy — Nyuta Federmesser, Head, Moscow Multidisciplinary Center for Palliative Care of the Moscow City Health Department.

Despite the huge focus on cell technologies, genetic engineering, Big Data and analytics, the incidence of cancer is going up alongside with the increase in life expectancy. By 2025, we’ll have 20% more elderly people with cancer than now — Nina Kandelaki, President and CEO of GE Healthcare in Russia and the CIS.

A 75% increase in life expectancy by 1.5 years happened due to the use of innovative vaccines — Taiji Tsukamoto, Chairperson and President of Sapporo Medical University.

There are many factors that contribute to an increase in life expectancy. The health insurance system is one of the most important factors — Taiji Tsukamoto, Chairperson and President of Sapporo Medical University.

We have insurance coverage for occupational diseases. This type of insurance was introduced 18 years ago, but unfortunately it never worked. In our country, occupational diseases are either not identified, or if they are, they never involve insurance companies or relevant procedures to determine cause-and-effect. Connection to hazardous operations is never identified, or it is revealed at the latest stages — Maxim Topilin, Minister of Labour and Social Protection of the Russian Federation.

When it comes to healthcare, death rate reduction is crucial — Vladimir Chekhonin, Vice President, Russian Academy of Sciences; Head of the Department of Medical Nanobiotechnology of Medical and Biological Faculty, N.I. Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation.

The first crucial thing not just for the health care system, but for society in general is reducing child mortality from external causes. 25% of children die at the prehospital phase. 7% of children in their first year of life die from external causes, while in the second year it’s 20%. <...>Secondly, it’s infection control, which will seriously improve health condition for children and teenagers. Lastly, we need to move from the so-called one time effects from pharmaceuticals and various medical exposures for children to the use of calculable technological solutions. For example, this would be perinatal technologies — Grigory Roytberg, CEO of Medicina.

We need to look at common problems in the health care system, such as insufficient budget — Olivier Charmeil, Executive Vice President and General Manager, General Medicines and Emerging Markets, Sanofi.

An important challenge for the industry is the lack of doctors, especially in the public system — Airat Farrakhov, Deputy, Member of the Committee on Budget and Taxes, State Duma of the Federal Assembly of the Russian Federation.

Today, the main problem of health care is medical personnel training. Their qualification is not at the level we need — Grigory Roytberg, CEO of Medicina.

Healthcare is the most profitable branch of our economy. We need to invest in this industry — Victor Cherepov, Executive Vice President of the Russian Union of Industrialists and Entrepreneurs (RSPP).

People expect that the government will ensure a good level of health care system. Investing in health today can be a tremendous impetus for the development of the country and society — Siman Tov Bar Moshe, Director General of the Ministry of Health of the State of Israel.

There are six key success factors: stimulating competition and making the system a market based one; applying new technologies; investing in the quality development of primary care; prevention and healthy lifestyle; focusing on doctors – integrating them into the global community and providing them with access to international medical knowledge and expertise; changing appraisal of health care performance — Ekaterina Timofeeva, Partner and Managing Director of The Boston Consulting Group.

If we use a personalized approach, we will not only improve treatment results, but we’ll be able to manage the budget more efficiently as well — Olivier Charmeil, Executive Vice President and General Manager, General Medicines and Emerging Markets, Sanofi.

If we use Big Data in the medical industry and genetics and if we can link it to certain genes, then we will see that the effect of medications on different people is different — Siman Tov Bar Moshe, Director General of the Ministry of Health of the State of Israel.

We must prevent the disease, diagnose it faster and treat it using scientific achievements, including digital technology, which will fundamentally change the entire health care system in the coming years — Andrew Lane, Executive Vice President, Abbott Laboratories.

Early diagnosis is very important. Innovative medicine will make a great contribution to increasing life expectancy — Jan Olof Jacke, President of AstraZeneca AB.